Sagian Equity
VC Fund
Zionsville, United States
Sagian Equity is a private investment firm.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Sagian Equity invests in
Stages Sagian Equity invests in
Countries Sagian Equity invests in
Investment Focus
Industry
- Health Care 1 (50%)
- Biotechnology 1 (50%)
- Medical Device 1 (50%)
- Health Diagnostics 1 (50%)
Stage
- Series C 1 (50%)
- Series D 1 (50%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
NanoCellect Biomedical
|
NanoCellect Biomedical, Inc. aims to make flow cytometry and cell sorting technology more affordable and accessible for life science researchers to perform cellular analysis, develop molecular diagnostics, and improve personalized medicine.A critical element for biomedical research is the ability for scientists to analyze and isolate cellsusing flow cytometers. Scientists use flow cytometers to obtain a fast, objective and quantitative recording of fluorescent signals from individual cells as well as physical separation of cells of particular interest.NanoCellect's mission is to facilitate breakthrough biomedical discoveries by making cell analysis and sorting technology more portable, affordable, and easier to use. We use microfluidics to make flow cytometers that enable biomedical scientists to analyze and sort cells required for drug discovery, diagnostics, or basic research. | $20M / Series D / Aug 13, 2021 | |
|
NanoCellect Biomedical
|
NanoCellect Biomedical, Inc. aims to make flow cytometry and cell sorting technology more affordable and accessible for life science researchers to perform cellular analysis, develop molecular diagnostics, and improve personalized medicine.A critical element for biomedical research is the ability for scientists to analyze and isolate cellsusing flow cytometers. Scientists use flow cytometers to obtain a fast, objective and quantitative recording of fluorescent signals from individual cells as well as physical separation of cells of particular interest.NanoCellect's mission is to facilitate breakthrough biomedical discoveries by making cell analysis and sorting technology more portable, affordable, and easier to use. We use microfluidics to make flow cytometers that enable biomedical scientists to analyze and sort cells required for drug discovery, diagnostics, or basic research. | $15M / Series C / Feb 01, 2021 |
Co-Investors
FusionX Ventures
2 deals together
Illumina Ventures
2 deals together
Vertical Venture Partners
2 deals together
Agilent Ventures
1 deal together
Anzu Partners
1 deal together
Casdin Capital
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Sagian Equity invest in?
Sagian Equity invests primarily in Health Care, Biotechnology and Medical Device startups, most often at Series C and Series D stage. Most of the 2 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Sagian Equity last invest?
The most recent investment recorded for Sagian Equity closed in Aug 2021. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
